"Perfume is the new smoking" is the sort of phrase designed to travel faster than the evidence behind it. It is meant to convey an alarming idea: something once considered sophisticated and socially acceptable is revealed to be dangerous, inconsiderate, and destined for public rejection. It is also a deeply misleading comparison. This does not mean that fragrance is harmless; it can cause allergic contact dermatitis and trigger respiratory symptoms, headaches, or nausea in sensitive individuals. Heavily scented products can make shared spaces difficult for people with asthma and other health conditions. The FDA acknowledges both skin and respiratory reactions to fragrance ingredients, while the American Academy of Dermatology identifies fragrance as one of the most common causes of allergic contact dermatitis.
Those are legitimate concerns, but they do not make perfume comparable to tobacco.
Cigarette smoking is addictive and has been conclusively established as a direct cause of cancer, cardiovascular disease, respiratory disease, and premature death. Tobacco smoke contains thousands of chemicals, including numerous known carcinogens. Exposure harms not only smokers but also the people around them; secondhand smoke has no risk-free level of exposure. These conclusions rest on decades of evidence. According to the National Cancer Institute, tobacco use remains the leading preventable cause of cancer and cancer deaths.
However, no comparable body of evidence demonstrates that ordinary use of fine fragrance causes population-wide disease or mortality on anything approaching that scale. Perfume is not addictive in the pharmacological sense. Wearing it does not expose bystanders to combustion products. Nor is there evidence that applying perfume to the neck uniquely damages the thyroid or causes cancer because of the organ’s proximity to the application site.
Calling perfume "the new smoking" substitutes analogy for evidence.
Much of the current alarm around fragrance relies on a basic confusion between hazard and risk. A substance may be capable of causing harm under some circumstances, at some concentration, or by some route of exposure. That is a hazard. Risk asks a different question: how likely is that harm under the conditions in which people are actually exposed? This distinction matters because modern analytical equipment can detect substances at extraordinarily low levels. Finding a chemical associated with a health hazard does not, by itself, establish that a product contains enough of it to cause harm through normal use.
A recent peer-reviewed analysis of 113 personal-care and cleaning products found that 98 percent contained at least one chemical not disclosed on the label, and 85 percent contained an undisclosed chemical with a known or suspected hazard. Those findings deserve attention and point to deficiencies in ingredient disclosure, supply-chain controls, and finished-product testing. But the study did not establish that the detected substances caused illness at the concentrations found. Its product categories included such items as shampoo, lotion, deodorant, sunscreen, baby products, essential oils, and household cleaners; it was not a study of fine fragrance as a category. Some undeclared chemicals may have entered products through contaminated raw materials, manufacturing processes, chemical reactions, or packaging rather than intentional concealment. The appropriate conclusion is that product transparency and testing need improvement, not that a bottle of perfume is equivalent to a pack of cigarettes.
However, the industry cannot dismiss these fears as mere internet hysteria while continuing to rely on opacity. In the United States, individual components of a fragrance formula generally do not have to be listed on a cosmetic label. They may be covered collectively by "fragrance" or "parfum." This can prevent consumers from determining whether a fragrance contains ingredients such as diethyl phthalate, or DEP. The FDA currently states that it has no safety concerns about DEP as used in cosmetics and fragrances and no evidence that phthalates in their present cosmetic uses pose a safety risk. That is more reassuring than viral claims suggest, but it does not eliminate the consumer’s reasonable interest in knowing what a product contains. Trade-secret protection may be commercially understandable, but it creates an information vacuum. Into that vacuum come sweeping claims about "toxins," endocrine disruption, and cancer. The industry’s traditional response, essentially, "trust us, the formula is proprietary," is no longer sufficient for many consumers. Greater disclosure, stronger supply-chain oversight, and more finished-product testing would make exaggerated accusations less persuasive. So would clearer explanations of exposure, concentration, and the safety restrictions already applied to fragrance materials.
The backlash has also created a profitable market for brands promising "clean," "non-toxic," or "chemical-free" fragrance. Such language often generates more confusion than clarity. Everything in perfume, including water, essential oils, and botanical extracts, consists of chemicals. Natural origin does not guarantee safety, and synthetic origin does not establish danger. The FDA specifically cautions that plant-derived ingredients can be irritating or allergenic, even toxic. Some citrus oils, for example, can cause adverse skin reactions when followed by sun exposure.
"Clean" frequently functions as a marketing position rather than a consistently defined safety standard. A brand may exclude a selected list of ingredients without demonstrating that its alternatives are safer. Fear of conventional fragrance can therefore become a sales tool for products that remain fragranced and may contain many of the same classes of allergens. Consumers deserve specific information, like which substances were excluded and why, what replaced them, and what evidence supports the claimed benefit.
Rejecting the smoking analogy should not become an excuse for disregarding other people’s symptoms. A fragrance may be safe for most users and still cause a serious reaction in a particular person. Offices, medical settings, schools, theaters, and public transportation are shared environments, and applying perfume heavily, or spraying it in a communal space, can impose an avoidable burden on others. Reasonable fragrance etiquette is not an admission that perfume is poisonous; it is recognition that scent travels and that individual tolerances differ. Wearing less fragrance in close quarters and respecting fragrance-free policies are courtesies everyone can afford.
The choice is not between declaring perfume toxic and insisting that it is perfectly harmless. Neither position reflects the evidence. A responsible discussion should distinguish allergic and sensory reactions from systemic toxicity, and distinguish the presence of a chemical from a meaningful dose. It should also distinguish genuine shortcomings in regulation and disclosure from unsupported claims that perfume causes cancer when sprayed near a particular organ. Perfume is a complex cosmetic product. It should be manufactured responsibly, regulated intelligently, labeled as transparently as practical, and worn with consideration for others. Its ingredients and health effects should continue to be studied.
But "the new smoking" is not a scientific assessment. It is a slogan, and one that takes real but limited concerns and inflates them into a false equivalence. That may be effective content marketing. It is not an effective way to communicate risk.
Reference: Jenna Hua et al., “Hidden Hazards: Nontargeted Chemical Analysis Reveals Widespread Contaminants and Mislabeling in Personal Care and Cleaning Products,” Environment & Health, August 11, 2026. https://doi.org/10.1021/envhealth.6c00181
-----------------------
Posted by theminx on Minxstinks
Note: this post is my opinion. I am not affiliated with the companies mentioned in this post or any other companies.
